- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06250725
Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners (SLEEPMATE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Disturbed sleep is stressful to persons living with dementia (PLwD) and their caregivers. It contributes to the earlier placement of the PLwD in nursing homes and increases the risk for many psychological and cognitive health issues and poor quality of life for both the PLwD and the caregivers. Given the potential harmful side effects of medications, non-medication alternatives, such as Cognitive Behavioral Therapy for Insomnia (CBTi), may be safer to improve disturbed sleep in this population. CBTi which includes stimulus control, sleep compression, relaxation, sleep hygiene, and cognitive restructuring, is effective and has durable and sustained effects on sleep outcomes over the long term. CBTi has improved sleep disturbances in PLwD and their caregivers, separately. Since disturbed sleep in the PLwD-caregiver dyad is bidirectional and interdependent, targeting the pair as a unit for intervention has the potential to lead to improved sleep and health outcomes for both persons.
There is no current published research on CBTi when the PLwD and their caregivers receive the intervention at the same time; as a result, the research team aims to examine the 1) feasibility and 2) preliminary efficacy of 6-week CBTi intervention for community-dwelling PLwD and their caregivers who are both experiencing sleep disturbances. PLwD-caregiver dyads will participate in videoconferencing sessions. In addition, semi-structured interviews will take place to examine the acceptability and satisfaction with the intervention.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Glenna S Brewster, PhD, RN, FNP
- Phone Number: (404) 712-9164
- Email: glenna.brewster@emory.edu
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Recruiting
- Emory Healthcare System
-
Contact:
- Rashidat Ayantunji
- Phone Number: 404-727-9953
- Email: rayantu@emory.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria for the PLwCI:
- Diagnosis of Alzheimer's Disease and Related Dementias (ADRD), or caregiver-reported probable or possible cognitive impairment based on electronic medical records or prescribed medications or
- Montreal Cognitive Assessment (MOCA) score between 12 and 24;
- Had ≥1 sleep problem ≥3x/week on the Neuropsychiatric Inventory (NPI)-Nighttime Behavior Subscale;
- Have an eligible caregiver;
- Be able to participate meaningfully in an interview
Inclusion Criteria for Caregivers:
- ≥18 years old, co-residing with persons living with cognitive impairment (PLwCI);
- Regularly assist the care recipient with ≥1 of 7 basic activities of daily living or
- ≥1 of 7 Instrumental Activities of Daily Living for the past 6 months;
- Have a Pittsburgh Sleep Quality Index (PSQI) of 5 or greater
Exclusion Criteria:
- PLwCI: Moderate to severe cognitive impairment
- Individuals who are not yet adults
- Pregnant women
- Prisoners
- Individuals who are not able to clearly understand English.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cognitive Behavioral Therapy for Insomnia (CBTi)
Participant dyads will receive CBTi via videoconferencing sessions
|
The intervention protocol will include CBTi principles like stimulus control, sleep compression, relaxation, sleep hygiene, and cognitive restructuring.
It will be done over 6 weeks with one session weekly via videoconference.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in insomnia
Time Frame: Baseline, 1-week post-intervention, and 3 months post-intervention
|
Insomnia will be measured using the Insomnia Severity Index. The insomnia severity index ahs seven questions. The seven answers are added up to get a total score. Total score categories: 0-7= No clinically significant insomnia 8-14= Subthreshold insomnia 15-21= Clinical insomnia (moderate severity) 22-28= Clinical insomnia (Severe) |
Baseline, 1-week post-intervention, and 3 months post-intervention
|
Change in Sleep Efficiency
Time Frame: Baseline, 1-week post-intervention, and 3 months post-intervention
|
Sleep Efficiency will be measured using sleep diaries and actigraphy.
Actigraphy watches monitor sleep-wake cycles by recording activity patterns continuously.
Participants will also complete a diary each morning that asks about their sleep-wake patterns.
|
Baseline, 1-week post-intervention, and 3 months post-intervention
|
Change in in Sleep Onset Latency
Time Frame: Baseline, 1-week post-intervention, and 3 months post-intervention
|
Sleep onset latency will be measured using sleep diaries and actigraphy.
Actigraphy watches monitor sleep-wake cycles by recording activity patterns continuously.
Participants will also complete a diary each morning that asks about their sleep-wake patterns.
|
Baseline, 1-week post-intervention, and 3 months post-intervention
|
Change in Wake After Sleep Onset
Time Frame: Baseline, 1-week post-intervention, and 3 months post-intervention
|
Wake after sleep onset will be measured using sleep diaries and actigraphy.
Actigraphy watches monitor sleep-wake cycles by recording activity patterns continuously.
Participants will also complete a diary each morning that asks about their sleep-wake patterns.
|
Baseline, 1-week post-intervention, and 3 months post-intervention
|
Adherence with Study Interventions (feasibility)
Time Frame: weekly during the intervention period up to 3 months post-intervention
|
Feasibility of the interventions will be assessed with rates of adherence to the study components throughout the study participation.
|
weekly during the intervention period up to 3 months post-intervention
|
Satisfaction with intervention components
Time Frame: 1 week post-intervention
|
Satisfaction with the intervention components will be assessed with the study satisfaction measure questionnaire that has 16 questions type that uses an agree, disagree scale as a range of answer options that go from strongly agree to strongly disagree.
|
1 week post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in depression
Time Frame: Baseline, 1-week post-intervention, and 3 months post-intervention
|
Depression will be measured using the Center for Epidemiologic Studies Depression scale. The Center for Epidemiologic Studies Depression scale has 20 questions. The 20 answers are added up to get a total score between 0 and 60. Total score categories: 16 or greater = Clinically significant depressive symptoms |
Baseline, 1-week post-intervention, and 3 months post-intervention
|
Change in the Quality of Life
Time Frame: Baseline, 1-week post-intervention, and 3 months post-intervention
|
Quality of Life will be measured using the research and development (RAND) Medical Outcomes short form (SF)-36.
The insomnia severity index has 36 questions which have subscales that total 100.
The lower the score the more disability.
The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
|
Baseline, 1-week post-intervention, and 3 months post-intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Glenna Brewster, PhD, RN, FNP, Emory University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00006711
- 5K23AG070378-03 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on Cognitive Behavioral Therapy for Insomnia
-
University of Kansas Medical CenterCompletedMultiple SclerosisUnited States
-
University of ArizonaRecruitingSleep Initiation and Maintenance DisordersUnited States
-
Stanford UniversityNational Institute of Nursing Research (NINR)Completed
-
Dartmouth-Hitchcock Medical CenterCrohn's and Colitis FoundationCompletedPain | Inflammation | Insomnia | Sleep Disturbance | Crohn DiseaseUnited States
-
Balearic Islands Health Service (Ibsalut)Completed
-
Southeast Louisiana Veterans Health Care SystemVISN 16 Mental Illness Research, Education and Clinical Center (MIRECC)CompletedSleep Initiation and Maintenance DisordersUnited States
-
University of RochesterNational Institute on Aging (NIA)CompletedInsomnia | Knee Pain | Osteoarthritis of the KneeUnited States
-
University of RochesterNational Institute of Nursing Research (NINR)CompletedDepression | Sleep | Stress Disorders, Post-TraumaticUnited States
-
University of California, DavisRecruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingGambling Disorder TreatmentFrance